Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial

Documenti analoghi

• Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
  di: Nathaniel M. Schuster, et al.
  Pubblicazione: (2025)
• A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
  di: Jeffrey D. Sharon, et al.
  Pubblicazione: (2024)
• Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
  di: Emmanuelle A. D. Schindler, et al.
  Pubblicazione: (2025)
• Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
  di: Muneto Tatsumoto, et al.
  Pubblicazione: (2024)
• Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
  di: Larry Charleston, et al.
  Pubblicazione: (2026)